This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Impact Biomedicines, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sharmila Das: Innovator in Cancer Treatment
Introduction
Sharmila Das is a prominent inventor based in North Brunswick, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions.
Latest Patents
Sharmila Das holds a patent for "BET inhibitors as a treatment for myelofibrosis." This patent outlines methods, pharmaceutical compositions, and kits designed to treat cancer in patients. The methods involve administering a BET (bromodomain and extra-terminal protein) inhibitor, or a pharmaceutically acceptable salt thereof, either alone or in combination with one or more JAK inhibitors. Additionally, the patent provides details on medicaments for use in treating cancer.
Career Highlights
Throughout her career, Sharmila has focused on developing innovative solutions for complex medical challenges. Her work has been instrumental in advancing treatment options for patients suffering from myelofibrosis and other cancers.
Collaborations
Sharmila has collaborated with notable colleagues, including Ida Aronchik and Roxxana Valeria Beltran Valencia. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Sharmila Das is a trailblazer in the field of cancer treatment, with her patent for BET inhibitors showcasing her commitment to improving patient outcomes. Her contributions to medical research continue to inspire advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile